Category: tolebrutinib
-
Sanofi MS drug tolebrutinib misses goal in relapsing disease trials By Reuters
•
By Ludwig Berger (Reuters) – Sanofi Nasdaq:NASDAQ:NASDAQ:MSN’S most advanced multiple sclerosis drug failed to meet the main goal of two late-stage trials to treat recurrent forms of the disease, dimming the prospects for a broad class of drugs. The French drugmaker said on Monday that two phase 3 trials showed…